These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022 [TBL] [Abstract][Full Text] [Related]
28. Antioxidant strategies for Alzheimer's disease. Grundman M; Grundman M; Delaney P Proc Nutr Soc; 2002 May; 61(2):191-202. PubMed ID: 12133201 [TBL] [Abstract][Full Text] [Related]
29. Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease. Murakami K; Murata N; Ozawa Y; Kinoshita N; Irie K; Shirasawa T; Shimizu T J Alzheimers Dis; 2011; 26(1):7-18. PubMed ID: 21558647 [TBL] [Abstract][Full Text] [Related]
30. How to clean the dirtiest place in the cell: cationic antioxidants as intramitochondrial ROS scavengers. Skulachev VP IUBMB Life; 2005; 57(4-5):305-10. PubMed ID: 16036614 [TBL] [Abstract][Full Text] [Related]
31. Free radicals as mediators of toxicity in Alzheimer's disease: a review and hypothesis. Tabet N; Mantle D; Orrell M Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):127-52. PubMed ID: 10967748 [TBL] [Abstract][Full Text] [Related]
33. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease. Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066 [TBL] [Abstract][Full Text] [Related]
34. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404 [TBL] [Abstract][Full Text] [Related]
35. Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-κB activation: Use of insulin to attenuate metformin's effect. Picone P; Nuzzo D; Caruana L; Messina E; Barera A; Vasto S; Di Carlo M Biochim Biophys Acta; 2015 May; 1853(5):1046-59. PubMed ID: 25667085 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic potential of oxidant mechanisms in Alzheimer's disease. Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526 [TBL] [Abstract][Full Text] [Related]
37. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration. Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215 [TBL] [Abstract][Full Text] [Related]